The HPV Vaccine Discussion India Should Have

This document presents a comprehensive citizen-led research inquiry into Gardasil the Human Papillomavirus (HPV) vaccine manufactured by Merck its commercial scale generating 8. 6 billion annually for Merck; its exact ingredients including 500 mcg of aluminum adjuvant per dose identical in both USA and India; and the ongoing peer-reviewed scientific debate on whether injected aluminum can migrate to the brain and cause long-term neurological harm, a debate that the US CDC itself has not yet fully resolved as of 2025. A central finding is that India possesses its own indigenous HPV vaccine CERVAVAC, developed by the Serum Institute of India which was approved in 2022 and demonstrated clinical non-inferiority to Gardasil. Yet India's national programme deploys the foreign-manufactured Gardasil instead, a situation explained partly by the diversion of CERVAVAC's production infrastructure toCOVID-19 vaccine manufacturing, and partly by Merck's strategic pricing through the Gavi vaccine alliance that effectively neutralises any commercial incentive to scale CERVAVAC production a pattern consistent with predatory pricing. The document further identifies a critical human rights gap at the heart of India's vaccination policy: the complete absence of a National Vaccine Injury Compensation Programme. While the United States has paid over 5 billion to 7, 807 vaccine-injured individuals through a no-fault, free-to-access special court system since 1986, India has paid zero leaving vaccine-injured citizens to fight government lawyers in regular courts at their own expense, with no defined timelines, no independent adjudicators, and no guaranteed relief. This gap is examined through the lens of Article 21 of the Indian Constitution, which the Supreme Court has held protects bodily integrity and the right to refuse medical treatment a powerful constitutional protection that remains largely unenforced in practice. Finally, the document proposes five concrete legislative reforms: a National Vaccine Injury Compensation Act on the no-fault model; a Mandatory Informed Consent Act for public health programmes; a Transparency Amendment to the Drugs and Cosmetics Act; an Indigenous First National Vaccine Policy; and a Children's Medical Rights Act codifying the Supreme Court's Article 21 rulings into enforceable statute. These reforms collectively represent the minimum legal infrastructure required for India's HPV vaccination programme or any mass vaccination programme to meet the standards of informed consent, transparency, accountability, and justice that medical ethics and human rights law demand. The core position of this document is not anti-vaccination. It is pro-rights. Cervical cancer kills approximately 200 Indian women every single day and prevention is urgently needed. But the rights, dignity, and safety of the girls who receive these vaccines are equally non-negotiable. Both goals cancer prevention and rights protection are achievable together, provided the government acts with transparency, accountability, and genuine respect for the citizens it serves.